Project Grant R03CA289066
Award Date
9/13/24
Completion Date
8/31/26
Dollars Obligated
$157K
Federal Agency
National Cancer Institute
Federal Grant Program
93.393
Assistance Type
Project Grant
Place of Performance
Columbia, MO 65211, USA
Similar Awards
This $162,190 federal Project Grant award from the National Institute of Nursing Research (NINR) under CFDA 93.361 Nursing Research supports the development and pilot testing of a peer-led, web-based psychosocial support intervention for Black breast cancer survivors. The primary goal is to examine the feasibility, acceptability, and preliminary efficacy of the intervention in reducing distress and improving health-related quality of life among this population, who experience...
This federal Project Grant award of $334,233, awarded by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program, will support a comprehensive research study examining disparities in novel cancer therapies, the joint effects of cancer treatment and comorbidities, and multi-level contributors to cancer survival outcomes. The University of South Carolina, the prime awardee, will conduct innovative data linkages between the state cancer registry,...
The National Cancer Institute awarded a $684,333 Project Grant under the Cancer Detection and Diagnosis Research program (CFDA 93.394) to The Trustees of Columbia University in the City of New York. The project, titled "Integrating Breast Cancer and Cardiovascular Disease Risk to Explore Decision-Making for Chemoprevention Among Racially/Ethnically Diverse Women at High Risk for Breast Cancer," aims to evaluate if patient and provider decision support that juxtaposes breast cancer...
The National Cancer Institute awarded a 5-year, $516,114 Project Grant (CFDA 93.395 Cancer Treatment Research) to The University of Texas MD Anderson Cancer Center to investigate the impact of immediate lymphatic reconstruction (ILR) surgery on preventing lymphedema in patients with inflammatory breast cancer. The key products or services to be delivered under this grant include: Conducting near-infrared fluorescence lymphatic imaging (NIRF-LI) to longitudinally assess changes in lymphatic...
This $1,073,982 National Cancer Institute project grant will fund research at Washington University in University City, Missouri from January 2023 through December 2027 under the Cancer Cause and Prevention Research program (CFDA 93.393). The research aims to document unmet social needs among 300 patient-caregiver dyads where the patient has breast or gynecologic cancer. It will analyze how social needs affect biopsychosocial outcomes for patients and caregivers, including depressive symptoms,...
This federal Project Grant award, provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393), supports a $644,804 research project titled "Advancing Breast Cancer Risk Assessment for Black Women." The project aims to develop and validate a novel deep learning-based breast cancer risk assessment tool focused on Black women, leveraging digital breast tomosynthesis (DBT) imaging data. Key objectives include: Developing a DBT-driven...
This federal Project Grant award from the National Cancer Institute (CFDA 93.395 - Cancer Treatment Research) will provide $402,401 to the University of Missouri System to conduct a pilot study on the feasibility and impact of a metacognitive strategy training (MCST) intervention for women with cancer-related cognitive impairment (CRCI) following breast cancer treatment. The study aims to examine the effects of MCST on cognitive performance, frontoparietal neural functioning, and functional...
The National Cancer Institute (NCI) awarded a $734,785 Project Grant under the Cancer Cause and Prevention Research (CFDA 93.393) program to Vanderbilt University Medical Center. The 5-year grant, effective September 1, 2024, will fund a proteogenomics study to identify proteins associated with breast cancer risk. The study will integrate genomics and proteomics data from over 5,000 normal breast tissue samples and 125 breast cancer tissue samples to discover putative target proteins for...
This federal Project Grant award in the amount of $432,304 was provided by the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research (CFDA 93.393) program. The award supports the development of novel data integration methods to enhance cancer risk predictions, particularly for underrepresented Black and Hispanic populations. The key products and services to be delivered include: A transfer learning method that integrates shared knowledge from external studies to leverage...
This $968,999 federal Project Grant award from the National Cancer Institute (CFDA 93.393 - Cancer Cause and Prevention Research) will support a study to optimize imaging-based surveillance for lung cancer survivors treated with curative-intent surgery. The primary objectives are to: 1) determine real-world patterns and effectiveness of imaging surveillance, 2) develop and validate risk prediction models for lung cancer recurrence and second primary lung cancer using imaging biomarkers from...